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Abstract
Background: Burkholderia cenocepacia, an opportunistic pathogen that causes lung infections in cystic fibrosis (CF)
patients, is associated with rapid and usually fatal lung deterioration due to necrotizing pneumonia and sepsis, a
condition known as cepacia syndrome. The key bacterial determinants associated with this poor clinical outcome
in CF patients are not clear. In this study, the cytotoxicity and procoagulant activity of B. cenocepacia from the ET-
12 lineage, that has been linked to the cepacia syndrome, and four clinical isolates recovered from CF patients
with mild clinical courses were analysed in both in vitro and in vivo assays.
Methods: B. cenocepacia-infected BEAS-2B epithelial respiratory cells were used to investigate the bacterial
cytotoxicity assessed by the flow cytometric detection of cell staining with propidium iodide. Bacteria-induced
procoagulant activity in cell cultures was assessed by a colorimetric assay and by the flow cytometric detection of
tissue factor (TF)-bearing microparticles in cell culture supernatants. Bronchoalveolar lavage fluids (BALF) from
intratracheally infected mice were assessed for bacterial proinflammatory and procoagulant activities as well as for
bacterial cytotoxicity, by the detection of released lactate dehydrogenase.
Results: ET-12 was significantly more cytotoxic to cell cultures but clinical isolates Cl-2, Cl-3 and Cl-4 exhibited also
a cytotoxic profile. ET-12 and CI-2 were similarly able to generate a TF-dependent procoagulant environment in
cell culture supernatant and to enhance the release of TF-bearing microparticles from infected cells. In the in vivo
assay, all bacterial isolates disseminated from the mice lungs, but Cl-2 and Cl-4 exhibited the highest rates of
recovery from mice livers. Interestingly, Cl-2 and Cl-4, together with ET-12, exhibited the highest cytotoxicity. All
bacteria were similarly capable of generating a procoagulant and inflammatory environment in animal lungs.
Conclusion: B. cenocepacia were shown to exhibit cytotoxic and procoagulant activities potentially implicated in
bacterial dissemination into the circulation and acute pulmonary decline detected in susceptible CF patients.
Improved understanding of the mechanisms accounting for B. cenocepacia-induced clinical decline has the
potential to indicate novel therapeutic strategies to be included in the care B. cenocepacia-infected patients.
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Over the last decades, Burkholderia cenocepacia has
emerged as an important respiratory pathogen in the
cystic fibrosis (CF) community. Pulmonary colonization/
infection by these bacteria may persist for months or
even years but a minority of patients exhibits a rapid
clinical deterioration associated with severe respiratory
inflammation, epithelial necrosis and invasive disease, a
condition known as cepacia syndrome [1]. Despite
intense research efforts, the detailed pathogenic
mechanisms underlying this poor outcome of CF
patients are not clear. B. cenocepacia ability to induce a
marked release of proinflammatory mediators [2-4] is
likely to contribute to lung damage and respiratory fail-
ure but whether bacterial isolates recovered from
patients with poor clinical prognosis exhibit differential
virulence profile has been so far poorly investigated.
Increasing evidences suggest that inflammation and
coagulation are linked to and amplify each other. In
clinical settings associated with exacerbated inflamma-
tory response, uncontrolled activation of the coagulation
cascade leads ultimately to inadequate fibrin deposition
in host microvasculature [5]. In lungs, fibrin deposition
has also been demonstrated in the alveolar and intersti-
tial compartments [6,7]. Alveolar clotting processes
compromise the lung gas-exchange barrier. Moreover,
thrombin and fibrin degradation products may further
activate neutrophils and fibroblasts, contributing to lung
injury. Because the lungs of CF patients is characterized
by a florid inflammatory response, we wonder whether
alveolar clotting processes may be involved in the patho-
genesis of pulmonary decline observed in a proportion
of B. cenocepacia-infected CF patients.
Coagulopathy associated with inflammatory response
depends most notably on enhanced expression of tissue
factor (TF), the major physiological initiator of the coa-
gulation cascade [8]. Besides being expressed on differ-
ent cell types, TF can be released from cell surfaces and
circulate in extracellular fluids as a soluble fluid-phase
protein [9] or associated with microparticles [10] shed
from cell membranes upon cell activation and/or
damage. Because microparticles exhibit also anionic
phosphatidylserine at their surface, they provide a cata-
lytic surface promoting the assembly of the enzyme
complexes of the coagulation cascade, contributing to
the thrombogenicity of extracelular fluids [10,11].
Different pathogens have been shown to up-regulate
TF expression on human cells [12-14], thereby enhan-
cing their procoagulant potential but, to our knowledge,
the ability of B. cenocepacia to modulate TF expression
has not yet been investigated.
To address the deficiency in the knowledge of B. ceno-
cepacia pathogenicity, in the present study we compared
bacteria of the ET-12 epidemic lineage, that has been
linked to the cepacia syndrome [15], with four B. ceno-
cepacia clinical isolates (CI) recovered from the airways
of CF patients with mild clinical outcome in their
expression of virulence features potentially implicated in
invasive disease and lung function decline: cytotoxicity
towards airway epithelial respiratory cells and ability to
induce a procoagulant state in the lung environment.
Materials and methods
Bacterial strains and culture conditions
B. cenocepacia strain J2315, a member of the virulent
lineage known as electrophoretic type 12 (ET-12), was
provided by the Pasteur Institute microorganisms
depository. Clinical isolates (Cl-1 to Cl-4) were recov-
ered from the airway secretions of four different CF
patients and belong to B. cenocepacia subgroup IIIA.
Samples obtained from the patients were processed as
described previously [16]. Bacteria were grown on Tryp-
ticase Soy Broth at 37°C for about 18 h, harvested by
centrifugation and resuspended in M-199-HEPES med-
i u m( G i b c oB R L ,G a i t h e r s b u r g ,M D ,U S A )c o n t a i n i n g
10% fetal calf serum (FCS) to A660 nm = 0.1, correspond-
ing to about 10
8 colony forming units (CFU)/mL.
Airway epithelial cell culture
Transformed human bronchial epithelial cells from the
BEAS-2B cell line were cultured in M-199-HEPES medium
containing 10% FCS and glutamine (complete medium),
and seeded in 24-well tissue culture plates (0.4 × 10
5 cells
per well). After 48 h, cells were infected at a multiplicity of
infection of about 100 bacteria per cell. Bacteria were cen-
trifuged (1,000 g for 10 min) onto the cell monolayers
prior to incubation at 37°C for 1 h. Cells were then incu-
bated with complete culture medium containing gentami-
cin (1 mg/mL) and ceftazidime (1 mg/mL) for additional
19 h, to eliminate infecting microorganisms, as reported
[2]. Control non-infected cells were treated similarly.
Detection of bacterial cytotoxicity
Bacterial cytotoxicity was determined by the assessment
of cell staining with propidium iodide, a cell-imperme-
able nucleic acid binding dye that only permeates leaky
cell membranes [17]. Briefly, control and infected cells
were detached from the microplate wells with 0.05%
trypsin-0.02% EDTA solution, pooled with sponta-
neously detached cells present in culture supernatants,
centrifuged, ressuspended in PBS containing 1% bovine
serum albumin (PBS-BSA 1%), incubated with propi-
dium iodide at a final concentration of 2 μg/mL for 10
min and analyzes with a FACscalibur flow cytometer
(Becton Dickinson, Mountain View, CA, USA).
Detection of cell-associated TF
Control and infected cells were detached from the
microplate wells as described above, fixed with 4%
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with 0.01% Triton X-100 in PBS for 5 min, rinsed, incu-
bated with an anti-TF-FITC complex (American Diag-
nostica, Stanford, CT, USA) and analyzed by flow
cytometry.
Detection of TF and procoagunlant activity in cell culture
supernatant
The Imubind TF ELISA and Actichrome TF activity kits
(American Diagnostica) were used to quantify TF and
detect a procoagulant activity, respectively, in cell cul-
ture supernatants, according to the manufacturer’s
instructions.
Detection of TF-containing microparticles
Cell culture supernatants from control and infected cul-
tures were centrifuged at 1,200 g for 3 min, to remove
cell debris, and then centrifuged at 17,500 g for 30 min
at 15°C, to pellet microparticles. Pellets were washed,
treated simultaneously with the anti-TF-FITC and
annexin V-Alexa Fluor 647 (Molecular Probes, Eugene,
OR, USA) complexes for 30 min in ice and washed once
with PBS. Microparticles were resuspended in PBS-BSA
1% and analyzed for 1 min by flow cytometry. The
region corresponding to shed microparticles was gated
in side scatter versus fluorescent intensity dot plot
representations by using, as reference, a mix of fluores-
cent beads (Megamix; Biocytex, Marseille, France) of
diameters to cover the microparticles (0.5 μma n d0 . 9
μm), as described [14].
Analysis of chromosomal B. cenocepacia DNA restriction
profiles
Isolates were typed by pulse field gel electrophoresis
(PFGE) as described [18], following digestion of intact
genomic DNA with SpeI (Invitrogen). DNA fragments
were separated on 1% (w/v) agarose gels in 0.5% TBE
(Tris-borate-EDTA) buffer using a CHEF DRIII appara-
tus (Bio-Rad, Hercules, CA, USA) with 6 V/cm, pulsed
from 0.5 to 25 s, for 18 h and 30 to 60 s, for 3 h at 14°
C. Gels were stained with ethidium bromide and photo-
graphed under ultraviolet light.
In vivo assays
Female 8-12 wk old Swiss mice were injected intraperi-
toneally with cyclophosphamide (150 mg/kg) to induce
granulocytopenia and favour acute B. cenocepacia infec-
tion. After 48 h, mice were anesthetized with a mixture
of ketamine (65 mg/kg) and xylazine (13 mg/kg) admi-
nistered intraperitoneally and 5 × 10
7 CFU of each bac-
terial isolate in 50 μL of sterile LPS-free saline were
instilled into their tracheas. Control mice were instilled
with sterile LPS-free saline. After 24 h, mice were
anesthetized for blood collection by intracardiac punc-
ture (for bacteriological culture and the assessment of
leukocyte concentration), and killed by intraperitoneal
injection of sodium pentobarbital. Mice airways were
then washed with 1 mL of PBS, their livers were excised,
macerated and serially diluted with sterile saline. Bacter-
ial load in liver parenchyma was determined by plating
serial dilution of liver macerates on blood agar plates.
Mice bronchoalveolar lavage fluids (BALFs) were ana-
lysed for total leukocyte and protein concentration
(BCA Protein Assay kit, Pierce Biotechnology, Rockford,
IL, USA), as well as for lactate-dehydrogenase (LDH)
(Sigma-Aldrich, St Louis, MO, USA) and procoagulant
activity (American Diagnostica). Animal handling were
in accord with the guidelines of the Animal Ethics
Research Committee of the State University of Rio de
Janeiro (protocol # CEA/210/2007).
Statistical analysis
Statistical analysis was performed using a one-way ana-
lysis of variance (ANOVA) with the Bonferroni’st e s tt o
determine significant differences between groups, unless
otherwise stated. P values < 0.05 were deemed to be
significant.
Results
B. cenocepacia isolates differed in their cytotoxicity
With the exception of Cl-1, all bacteria killed signifi-
cantly high percentages of airway cells (Fig. 1). B. ceno-
cepacia from the ET-12 lineage was shown to be
significantly more cytotoxic than the other isolates (p <
0.001, 0.01, 0.001 and 0.05 when compared with Cl-1,
Cl-2, Cl-3 and Cl-4, respectively).
B. cenocepacia did not modify the expression of TF by
infected cells but enhanced the release of TF into cell
supernatants
No significant difference between control and infected
cultures in their percentage of TF-expressing cells could
be detected (Fig. 2A), as well as their expression of TF
mRNA (data not shown). In contrast, TF concentrations
in supernatants from ET-12- and Cl-2-infected cultures
were significantly higher than in supernatant from non-
infected cultures and from cultures infected with the
other clinical isolates, Cl-2 infection being the most
important stimulus for TF release (Fig. 2B).
The biological relevance of released TF was next
investigated. Fig. 2C shows that the supernatants from
ET-12 and Cl-2-infected cells exhibited a significantly
augmented procoagulant activity when compared with
supernatants from control cultures and from cultures
infected with the other clinical isolates (p < 0.01 for Cl-
1 and p < 0.05 for Cl-3 and Cl-4).
B. cenocepacia enhanced also the release of TF-bearing
microparticles
Fig. 3A shows that the number of microparticles binding
annexin V, a protein known for its interaction with
negatively charged phosphatidylserine residues, was sig-
nificantly higher in supernatants from ET-12- and Cl-2-
infected cells than in supernatants from control cultures.
More importantly, a higher percentage of MPs shed
Cunha et al. Respiratory Research 2010, 11:4
http://respiratory-research.com/content/11/1/4
Page 3 of 9after ET-12 and Cl-2 infection, besides reacting with
annexin V, exhibited surface TF (Fig. 3B).
Genetic relatedness of the B. cenocepacia isolates
Because ET-2 and Cl-2 exhibited a similar virulence
profile, we wondered whether these two isolates were
clonally related. However, PFGE analysis showed that all
bacteria belonged to a different clonal group, with 70%
maximum similarity, with the exception of Cl-1 and Cl-
2 that exhibited exactly the same chromosomal DNA
profile (Fig. 4).
In vivo assays
Total leukocyte concentrations in peripheral blood from
mice infected with all clinical isolates were significantly
lower than in blood from control mice, testifying the
disease severity (Fig. 5A). All isolates were able to disse-
minate from the primary site of infection, as revealed by
positive hemocultures for B. cenocepacia in all infected
mice (data not shown). However, the percentages of Cl-
2- and Cl-4-infected mice with positive liver cultures
were higher than the percentages of mice infected with
the other bacterial isolate, including ET-12, although the
differences were not statistically significant (Fig. 5B).
Bacterial concentration were also higher in liver par-
enchyma from Cl 2- and Cl 4-infected mice (Fig. 5C).
Figure 1 Citotoxicity of B. cenocepacia assessed by FACS
detection of cell staining with propidium iodide (PI). (A) Means
(± SD) of the percentages of PI-stained cells detected in two assays
carried out at least in triplicate. **, p < 0.01 and ***, p < 0.001 when
data were compared with those from control non-infected cells; (B)
Representative histograms showing the PI staining intensity of
control and infected cells. y-axis corresponds to cell number
whereas x-axis corresponds to log fluorescence intensity.
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Figure 2 Modulation of TF expression in infected cultures.( A )
Percentage of TF-expressing cells in control and infected cultures,
determined by FACS analysis; (B) Concentration of TF in
supernatants from control and infected airway epithelial cell
cultures. (C) Procoagulant activity in cell culture supernatants. Data
are means (± SD) of the results obtained in at least two different
assays carried out in tripicate. *, p < 0.05 and **, p < 0.01 and p <
0.001 when data were compared with the results obtained with
control non-infected cultures.
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inflammatory environment in mice lungs, revealed by
significantly increased BALF concentrations of total pro-
tein and leukocyte (Fig. 6A and 6B, respectively). Most
cells in BALFs from control mice were mononuclear
(83.0% ± 15.9), whereas in fluids from infected animals
most cells were polymorphonuclear (from 84.0% ± 10.6
to 96.1% ± 3.2). LDH concentrations in samples from
infected mice were higher than in samples from control
mice, testifying the bacterial cytotoxicity, although statis-
tically significant differences were only detected when
BALFs from control mice were compared with BALFs
from ET-12-, Cl-2- and Cl-4-infected mice (Fig. 6C).
BALFs from all infected mice exhibited a significant TF-
dependent procoagulant activity (Fig. 6D).
Discussion
Bacteria causing respiratory infections in CF patients
typically remain confined to the endobronchial spaces.
In contrast, a proportion of B. cenocepacia-infected
patients exhibits an invasive disease, characterized by
bacterial extrapulmonary dissemination and systemic
inflammatory response [15]. The mechanisms that per-
mit bacteria to disseminate are not yet known but are
likely to involve penetration of airway barriers. In vitro
studies provided evidences that B. cenocepacia from the
ET-12 lineage can increase the permeability of and tra-
verses polarized respiratory epithelium [19] by the
dephosphorylation and dissociation of occludin from the
tight-junction complex [20]. However, increase in
epithelium permeability can also be secondary to epithe-
lial cell death resulting in breachs of the epithelium bar-
rier properties. Interestingly, evidences of damage to
airway epithelial cells in culture were detected in areas
subjacent to B. cenocepacia biofilms [19]. Cell damage
was also detected in airway epithelial cell cultures
infected with bacterial isolates carrying the cable pilin
gene (21), a distinctive feature of B. cenocepacia from
the ET-12 lineage [1]. More recently, purified cable pili
w e r ef o u n dt od i r e c t l yi n d u c ec y t o t o x i c i t yi na i r w a y
epithelial cells in vitro [22].
In the in vitro assays of this present study, besides ET-
12, most clinical B. cenocepacia isolates were shown to
kill airway epithelial cells but the specific virulence
determinant and the corresponding genetic element
required for B. cenocepacia cytotoxicity were not investi-
gated. Interestingly, in the in vivo assay, clinical isolates
accounting for the highest LDH concentration in mice
BALF (Cl-2 and Cl-4) were recovered in higher fre-
quency and concentrations in liver parenchyma. On the
basis of these results, it is tempting to suggest a
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Figure 3 Microparticle release from control and infected cells.
(A) Number of microparticles in control and infected cell culture
supernatants submitted to FACS analysis for 1 min; (B) Percentage
of TF positive/annexinV positive microparticles in supernatant from
control and infected cultures. Data are means (± SD) of the results
obtained in two assays carried out in triplicate. *, p < 0.05 and **, p
< 0.01 when data from control and infected cells were compared
with each other.
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Figure 4 PFGE profiles of genomic B. cenocepacia DNAs and dendogram resulting from computer analysis of PFGE profiles.
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nation into the circulation. However, since such rela-
tionship was not detected in ET-12-infected mice,
further studies are required to examine this hypothesis.
A huge inflammatory reaction is a hallmark of CF
patient lung parenchyma [15]. Because inflammation
almost invariably leads to the activation of the coagula-
tion cascade [5], and intra-alveolar fibrin deposition
plays a pathogenic role in lung dysfunction detected in
many acute inflammatory lung diseases [23], we won-
dered whether B. cenocepacia would induce a procoagu-
lant state in patient airspaces.
Increase of lung procoagulant state depends on
enhanced expression of TF by airway cells followed by
local TF-induced activation of the coagulation, in addi-
tion to being influenced by insufficiency of natural inhi-
bitors of coagulation and of the fibrinolytic system [24].
Prominent among the proinflammatory stimuli known
to modulate TF expression in monocyte and endothelial
cells is bacterial LPS [25]. LPS was also shown to upre-
gulate TF expression in lung tissues and fibrin deposi-
tion in the alveolar spaces, bronchioles and vessels of
experimental animals [26]. Because B. cenocepacia LPS
is a potent inducer of the inflammatory response
[27,28], we were surprised to find no increase in TF
expression in infected airway epithelial cells. A similar
result was recently described in airway cell cultures
infected with an ExoU-deficient P. aeruginosa strain
[14]. Since most in vitro studies showing the regulatory
effect of LPS on TF expression have been carried out
with monocyte/macrophages or endothelial cells, we
wonder whether the apparent contradiction between our
results and the others may have stemmed from differen-
tial response of these several cell types. Alternatively, it
is conceivable that the concentration of LPS released
from infecting bacteria during the experimental assays
m a yb em u c hl o w e rt h a nt h ec o n c e n t r a t i o no fp u r i f i e d
LPS used in those in vitro studies.
In contrast with the absence of modulation of TF
expression at airway cells surface, significantly increased
TF concentration and procoagulant activity were
detected in supernatants from ET-12- and Cl-2-infected
cells. These two bacterial isolates elicited also a signifi-
cant release of TF-bearing microparticles from airway
cells. Although the procoagulant activity detected in cul-
ture supernatants may have resulted from released solu-
ble fluid-phase TF, it most likely resulted from the
release of TF-bearing microparticle. This is so because
TF requires association with anionic lipids to become
procoagulant [29]. Whereas anionic lipids are not asso-
ciated with soluble fluid-phase TF, they are constitu-
tively expressed in microparticles. Studies showing that
circulating TF-bearing microparticles are often asso-
ciated with thrombotic propensity [10,11] corroborate
our hypothesis.
Differences between the results from B. cenocepacia-
induced procoagulant activity in cell culture superna-
tants and in mice BALFs are likely reflect the complex-
ity of the in vivo experimental model in which different
cell types are likely to contribute to the generation of
the procoagulant activity. Because TF expression in cells
from the monocytic lineage IS enhanced substantially
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Figure 5 (A) Blood leukocyte concentration in control and
infected mice. Data are means (± SD) of the results obtained in
two assays in which at least 12 animals from each group were
analysed. **, p < 0.01 and ***, p < 0.001 when data from control
and infected mice were compared with each other. (B) Percentage
of mice from each group with positive liver cultures; (C) Bacterial
concentration in liver parenchyma. **, p < 0.01 when data from Cl-
2- and Cl-4-infected mice were compared with data from the other
groups by the Wilcoxon nonparametric test.
Cunha et al. Respiratory Research 2010, 11:4
http://respiratory-research.com/content/11/1/4
Page 6 of 9upon cell activation, we wonder whether B. cenocepacia-
stimulated alveolar macrophage may have contributed
the generation of a potent TF-dependent procoagulant
activity in mice BALFs, surmounting a milder response
of airway epithelial cells.
In this report, in both in vitro and in vivo assays, Cl-2
was phenotypically similar to ET-12 B. cenocepacia but
these two bacteria exhibited a very different PFGE profile.
On the other hand, B. cenocepacia Cl-1 and Cl-2, that
were indistinguishable by PFGE analysis, differed mark-
edly in their virulence properties against airway cells.
B. cenocepacia possess very large genomes and sepa-
rate their DNA into three or more chromosomal repli-
cons which may add greater flexibility in the acquisition,
loss and expression of genes [30,31]. Indeed, genome-
sequencing projects have shown that 10% of more of
the Burkholderia genes have been acquired through
gene horizontal transfer and reside as elements of for-
eign DNA such as genomic islands, prophages or plas-
mids. Therefore, it is conceivable that genes encoding
virulence factors accounting for the cytotoxicity and
procoagulant activity of B. cenocepacia ET-12 and Cl-2
may reside as elements of foreign DNA that are not
possessed by all B. cenocepacia isolates and were not
detected by PFGE analysis. Similarly, foreign DNA
elements possessed by Cl-2, but not by Cl-1, would
explain why these two bacterial isolates, that exhibit the
same chromosomal DNA profile, have different viru-
lence phenotypes. Studies to examine this hypothesis are
currently in progress.
Conclusion
In this report, B. cenocepacia from the ET-12 lineage
and clinical isolates were shown to exhibit virulence fea-
tures potentially implicated in bacterial dissemination
into the circulation and acute pulmonary decline
detected in susceptible CF patients: cytotoxicity to air-
way epithelial cells, capability of enhancing the release
of TF-bearing microparticles from infected cells and
generating a TF-dependent procoagulant environment.
In vivo assays corroborated the B. cenocepacia cytotoxi-
city as well as the ability to generate a procoagulant and
inflammatory environment in mice airways.
Although differences between experimental models
and humans preclude direct extrapolation of results
from experimental studies to patients, on the basis of
our in vitro and in vivo evidences we speculate that at
least some B. cenocepacia isolates may be able to induce
a prothrombotic state in CF patient airways, ultimately
resulting in deposition of fibrin in airspaces. This
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Figure 6 (A) Total protein, (B) leukocyte, (C) LDH concentrations and (D) procoagulant activity in BALFs from control and infected
mice. Data are means (± SD) of the results obtained two assays in which at least 12 animals from each group were analysed *, p < 0.05, **, p <
0.01, ***, p < 0.001 when data from control and infected mice were compared with each other.
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thrombus formation in lung parenchyma of Pseudomo-
nas aeruginosa-infected mice with increased local pro-
coagulant activity [14,32]. Besides compromising the
lung gas-exchange barrier, airway clotting processes are
harmful because surfactant components may be incor-
porated into polymerizing fibrin with subsequent loss of
surface activity and alveolar instability, further contri-
buting to lung function deterioration. Improved under-
standing of the mechanisms accounting for B.
cenocepacia-induced procoagulant activity has the
potential to indicate novel therapeutic strategies to be
included in the care B. cenocepacia-infected patients.
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